Evidence map›Paper›PMID 26096937›Full record

ArticleOncogene2016

Comprehensive translational control of tyrosine kinase expression by upstream open reading frames.

K Wethmar, J Schulz, E M Muro, S Talyan, M A Andrade-Navarro, A Leutz

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

K WethmarDepartment of Cell Differentiation and Tumorigenesis, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.
J SchulzDepartment of Cell Differentiation and Tumorigenesis, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.
E M MuroDepartment of Computational Biology and Data Mining, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.
S TalyanDepartment of Biology, Institute of Molecular Biology, Johannes-Gutenberg University, Mainz, Germany.
M A Andrade-NavarroDepartment of Computational Biology and Data Mining, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.
A LeutzDepartment of Cell Differentiation and Tumorigenesis, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany.
Institute of Molecular Biology · DEHumboldt-Universität zu Berlin · DEJohannes Gutenberg University Mainz · DEMax Delbrück Center · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-transcriptional control has emerged as a major regulatory event in gene expression and often occurs at the level of translation initiation. Although overexpression or constitutive activation of tyrosine kinases (TKs) through gene amplification, translocation or mutation are well-characterized oncogenic events, current knowledge about translational mechanisms of TK activation is scarce. Here, we report the presence of translational cis-regulatory upstream open reading frames (uORFs) in the majority of transcript leader sequences of human TK mRNAs. Genetic ablation of uORF initiation codons in TK transcripts resulted in enhanced translation of the associated downstream main protein-coding sequences (CDSs) in all cases studied. Similarly, experimental removal of uORF start codons in additional non-TK proto-oncogenes, and naturally occurring loss-of-uORF alleles of the c-met proto-oncogene (MET) and the kinase insert domain receptor (KDR), was associated with increased CDS translation. Based on genome-wide sequence analyses we identified polymorphisms in 15.9% of all human genes affecting uORF initiation codons, associated Kozak consensus sequences or uORF-related termination codons. Together, these data suggest a comprehensive role of uORF-mediated translational control and delineate how aberrant induction of proto-oncogenes through loss-of-function mutations at uORF initiation codons may be involved in the etiology of cancer. We provide a detailed map of uORFs across the human genome to stimulate future research on the pathogenic role of uORFs.

Indexed as

Protein BiosynthesisGene Expression ProfilingGene Expression Regulation, EnzymologicGene Regulatory NetworksHEK293 CellsHeLa CellsHumansOpen Reading FramesProtein-Tyrosine KinasesProto-Oncogene MasMAS1 protein, humanProtein-Tyrosine KinasesProto-Oncogene Mas

Identifiers

PMID26096937
PMCPMC4820681
OpenAlexW1493490914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.